ACUTA CAPITAL PARTNERS, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 102 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.9%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$1,451,00058,5250.26%
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders